SEATTLE — Sept. 7, 2016 — Umbilical cord blood transplants may have advantages beyond offering an alternative stem cell source for leukemia patients without a traditional donor match, according to a ...
(SALT LAKE CITY) - A factor found in umbilical cord blood could become the basis for developing a new therapy to fight harmful inflammation, University of Utah School of Medicine researchers report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback